Decision Resources Lectures

The Lecture in Life Sciences & Management was established by Decision Resources of Burlington, MA, under the guidance of its co-founders, Samuel C. Fleming, CEO 1989 – 2003, and Sarah W. Fuller, C’71, President 1989 – present. As a global leader in providing strategic information to the biopharmaceutical, medical device and health-insurance industries, Decision Resources epitomizes the philosophy behind the LSM program. LSM is pleased to have Sam Fleming and Sarah Fuller as partners in presenting this annual series, which brings leaders in the fields of science and business to Penn’s campus.

Past Decision Resources lectures:

2016: David Fajgenbaum, M.D., M.B.A., M.Sc.

Co-Founder and Executive Directors of the Castleman Disease Collaborative Network (CDCN)

Research Assistant Professor of Medicine, Division of Translational Medicine & Human Genetics, Perelman School of Medicine, University of Pennsylvania

When Every Second Counts: Using Business Principles to Defeat Castleman Disease


2015: George Yancopoulos, M.D., Ph.D.

Founding Scientist, President, Regeneron Laboratories & Chief Scientific Officer, Regeneron

Building a Better Biotech: The Regeneron Story


2014: Jean Bennett, M.D., Ph.D.

F.M. Kirby Professor of Molecular Opthalmology, Perelman School of Medicine

Seeing is Believing: The Emergence of Rare Disease as a Stepping Stone to Drug Development

 

2013: Joaquin Duato

Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Future Forward: New Directions in Meeting Global Health Needs


2012: Paul Offit, M.D.

Chief, Division of Infectious Diseases, Children's Hospital of Pennsylvania, and Maurice R. Hilleman Professor of Vaccinology, University of Pennsylvana School of Medicine

Communicating Science to the Public


2011: Daniel Janzen, Ph.D.

DiMaura Professor of Conservation Biology, University of Pennsylvania, and
Founder, Área de Conservación Guanacaste
Conservation of a Large Tropical Wildland through its Biodiversity Development

2010: Margaret G. McGlynn

Former President of Global Vaccines and Anti-Infectives, Merck & Co., Inc.
Leveraging Science and Business Skills to Impact Global Health

2009: Barry R. Bloom, Ph.D.

Distinguished University Service Professor and Jack and Joan Jacobson Professor of Public Health, Harvard University School of Public Health
The Unfinished Agenda of Infectious Diseases

2008: Philip Needleman, Ph.D.

Former Professor and Chairman, Department of Pharmacology, Washington University Medical School, and Former Chief Scientist and Head of R&D, Monstanto/Searle/Pharmacia
Lessons Learned from Turning a Research Idea into a Drug Used by Millions

2007: Art Caplan, Ph.D.

Emanuel and Robert Hart Professor of Bioethics; Chair, Department of Medical Ethics,
and Director, Center for Bioethics, University of Pennsylvania
A Long and Winding Road: The Evolution of Bioethics from Bedside to Boardroom

2006: Steven A. Nichtberger, M.D.

President and CEO, Tengion, Inc.
Turning Scientific Advances into Transformational Products: Opportunities and Challenges for the Scientist-Business Leader